Analyst Price Target is $22.54
▲ +11.09% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Chr. Hansen Holding A/S in the last 3 months. The average price target is $22.54, with a high forecast of $22.54 and a low forecast of $22.54. The average price target represents a 11.09% upside from the last price of $20.29.
Current Consensus is
The current consensus among 5 contributing investment analysts is to hold stock in Chr. Hansen Holding A/S. This Hold consensus rating has held steady for over two years.
Chr. Hansen Holding A/S is a bioscience company, which engages in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures and Enzymes; Health and Nutrition; and Natural Colors. The Food Cultures and Enzymes segment produces and sells cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health and Nutrition segment manufactures and distributes products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The Natural Colors segment caters to the food and beverage industry. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Hørsholm, Denmark.